SZOT MATTHEW K (Chief Financial Officer) sold 26.6% of their position (3.60K shares) of CADRENAL THERAPEUTICS, INC. on the open market
Open‑market sale worth $50.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/28/2025ACC: 0001213900-25-103147
Officer· Chief Financial Officer
Since Jan 2023
-3.60K
Net shares
Net seller
$50.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.80K
Price / share
$13.99
Trade value
$25.18K
% of position
13.3%
10/24/2025
13.53K→11.73K
Common Stock
Direct
Shares
−1.80K
Price / share
$13.99
Trade value
$25.18K
% of position
15.3%
10/27/2025
11.73K→9.93K
Total
Net shares
−3.60K
Net value
-$50.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/24/2025 | S · Sale | −1.80K | $13.99 | $25.18K | 13.3% | 13.53K | 11.73K |
| Common Stock Direct | 10/27/2025 | S · Sale | −1.80K | $13.99 | $25.18K | 15.3% | 11.73K | 9.93K |
| Total | −3.60K | -$50.36K | ||||||
Derivative Transactions0
No derivative transactions reported